Steven W. Cole, PhD, is a Professor of Psychiatry & Biobehavioral Sciences and Medicine in the Division of Hematology-Oncology at the David Geffen School of Medicine at UCLA.  His research utilizes molecular genetics and computational bioinformatics to analyze the pathways by which social and environmental factors influence the activity of the human genome, as well as viral and cancer genomes.  He pioneered the field of human social genomics, and discovered the "Conserved Transcriptional Response to Adversity" that mediates health disparities via neural regulation of inflammatory and antiviral genes.  He collaborates with more than 200 research groups world-wide through his role as Director of the UCLA Social Genomics Core Laboratory, and is a member of the Jonsson Comprehensive Cancer Center, Associate Director of the Norman Cousins Center, and a Fellow of the American Association for the Advancement of Science.

Policy on Faculty and Sponsor Disclosure

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, committee members, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers/presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.